作者
Avital Beig, Jonathan M Miller, Arik Dahan
发表日期
2012/6/1
期刊
European journal of pharmaceutics and biopharmaceutics
卷号
81
期号
2
页码范围
386-391
出版商
Elsevier
简介
The purpose of this paper was to study the solubility–permeability interplay in formulation development for oral administration of poor aqueous solubility drugs. The apparent solubility of the lipophilic drug carbamazepine was measured in systems containing various levels of the co-solvent PEG-400. The corresponding permeability was then measured in the PAMPA assay and in the rat jejunal perfusion model. Thermodynamic activity was maintained equivalent in all permeability studies (50% saturation). PEG-400 increased carbamazepine solubility in a concentration-dependent fashion. Decreased carbamazepine intestinal permeability with increased apparent solubility was observed in both PAMPA and rat perfusion models. Additionally, we have shown that the intestinal absorption of carbamazepine is membrane-controlled, with essentially no effective barrier function of the unstirred water layer. A mass …
引用总数
20122013201420152016201720182019202020212022202320245713141011149510939